Kerala High Court invokes Mammootty film, rules government can invoke Section 100 for cancer drugs

The Kerala High Court has ruled that the government can invoke Section 100 of the Patents Act, 1970 to ensure affordable access to patented life-saving medicines, in a case that began with a breast cancer patient's plea and ended with a poignant reference to Mammootty's 1994 film Sukrutham .

A Suo Motu Case Born from Tragedy

The writ petition was originally filed by a retired bank employee suffering from HR+/HER2- metastatic breast cancer. She was prescribed Ribociclib, a CDK 4/6 inhibitor costing around ₹58,140 for a 21-day course. Before the court could hear the matter, the petitioner succumbed to her illness. However, the court, on September 16, 2022 , converted the petition into a suo motu proceeding titled In Re Exorbitant Pricing of Life Saving Patented Medicines , appointing Advocate Maitreyi Sachidananda Hegde as Amicus Curiae .

The Core Legal Question

The central issue was whether the Central Government could be directed to exercise its power under Section 100 of the Patents Act to authorize the use of the patent for Ribociclib to make the drug available at an affordable price. The petitioner and intervenors argued that the exorbitant pricing violated the right to life under Article 21 and the state's duty to improve public health under Article 47 . They contended that Section 100, read with Section 83 , empowers the government to use patented inventions for public purposes, especially when medicines are unaffordable.

Government and Patentees’ Objections

The Union of India , through Additional Solicitor General P. Sreekumar , argued that Section 100 applies only when the invention is used "for the purposes of Government " as defined in Section 99 , i.e., for the direct use of the government or its departments, not for supplying to the public at large. The patentee companies, Novartis AG (manufacturer of Ribociclib) and Eli Lilly (manufacturer of Abemaciclib), emphasized that patents are conditional and that pricing alone cannot justify invoking Section 100. They pointed to existing price controls and patient assistance programs.

Court’s Interpretation: Section 100 Covers Public Health

Justice Harisankar V. Menon, after an extensive analysis, rejected the narrow interpretation of " purposes of Government ." He noted that Section 100(4) explicitly includes the right to vend medicines and drugs, and Section 100(6) allows sale on a non-commercial basis to any person, including needy patients. The court relied on the Supreme Court 's observations in In Re Distribution of Essential Supplies and Services During Pandemic ( 2021 ) and the TRIPS Agreement 's flexibility for public health .

The judgment further emphasized Section 83 (d), (e), and (g) of the Patents Act, which state that patents should not impede public health and must be made available at reasonably affordable prices. Citing Article 47 and the right to life under Article 21 , the court held that "the term ' purposes of Government ' also includes the duty of the Government to improve public health as mandated under Article 47 ."

Data Deficit and Policy Decision

While affirming the legal scope of Section 100, the court declined to issue a positive direction to the government, holding that it is a policy decision that requires comprehensive data on affordability, patient numbers, and existing schemes. The court directed the government to collate such data and consider invoking Section 100 if necessary.

An Epilogue that Echoes a Classic

In a notable epilogue, Justice Menon referenced the Malayalam film Sukrutham ( 1994 ), written by Jnanpith laureate M.T. Vasudevan Nair and starring Mammootty. The film's protagonist, a journalist diagnosed with blood cancer, chooses not to undergo treatment due to the crushing financial burden. The judge observed, "It is highly distressing that despite the passage of more than three decades since this story was adapted into the movie vocabulary... the plight of patients and their families remains the same."

Key Observations

  • "The provisions of Section 100 of the Act are required to be invoked in circumstances where the Government is required to intervene, such as when the medicine is unaffordable on account of its exorbitant price."
  • "The term ' purposes of Government ' also includes the duty of the Government/State to improve public health as mandated under Article 47 of the Constitution of India ."
  • "Section 100 of the Act would include the entitlement of the Government to use the patent or invention for manufacturing the medicine covered by the patent and sell the same on a non-commercial basis to the needy patient."

The Decision

The court disposed of the writ petition with findings that Section 100 can be invoked for public health purposes, and directed the government to collect data and decide on its invocation. The court also placed on record its appreciation for the Amicus Curiae 's assistance.